Abata hires Leonard Dragone as CMO
Plus: Amylyx gets a head of international markets, and updates from Heron, Breye, Alvotech and more
Regulatory T cell therapy company Abata Therapeutics Inc. hired Leonard Dragone as CMO, to succeed co-founder and interim CMO Richard Ransohoff. Dragone was CMO at Sonoma Biotherapeutics Inc.; Ransohoff, who will become an adviser to the company, is a venture partner at Third Rock Ventures.
Neurodegenerative disease company Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) hired Masako Nakamura as general manager and head of international markets — Asia Pacific and Latin America. Nakamura was SVP, head of Asia at Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and held various roles during her decade at the Genzyme Corp. unit of Sanofi (Euronext:SAN; NASDAQ:SNY). ...